Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06173765 · ClinicalTrials.gov registry record · NA

Understanding Dose Related Effects of Strawberry

A NA study of Inflammation and Insulin Resistance, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Active
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT06173765 is a NA study of Inflammation and Insulin Resistance that is active but no longer recruiting, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 66 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06173765, a NA study of Inflammation and Insulin Resistance, is active but no longer recruiting, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The proposed research is designed to extend previous research findings building on the knowledge of strawberries as fruits that support a healthy immune and vascular system. The proposed research leverages a recently funded proposal by the USDA to study in greater depth inflammation, glucoregulation and oxidative stress defense and their relation to improving endothelial function and insulin sensitivity. Before and after strawberry intake, blood samples will be collected for monocyte (immune cells and source of inflammatory cytokines) isolation and activation via changes in cellular NF-κB and Nrf-2 (key transcription factors of inflammation/oxidative stress defense) status along with products of their activation (ie., plasma cytokines). Because inflammation and oxidative stress impairs endothelial function and insulin sensitivity, acutely and chronically, investigators will also study changes in vascular and insulin sensitivity status, assessing changes in vascular adhesion molecules, endothelial responsiveness through flow mediated vasodilation (ie., FMD) and insulin sensitivity using the Liquid Meal Tolerance (LMTT) if intravenous glucose tolerance test (IVGTT) method cannot be used due to supply chain issues of sterile Dextrose. Glucoregulation will be assessed by placing a Continuous Glucose monitoring (CGM) machine (Dexcom-6) to participants for 10 days at the beginning and at the end of the study period of intervention. The study will be a randomized, double-blinded, 3-arm parallel, 4-week, dose-response study. Individuals with chronic low grade inflammation will be sought to test the anti-inflammation - vaso-relaxing - insulin sensitivity effects of strawberry.

Interventions

  • OTHER freeze-dried whole strawberry powder 36 g powder
  • OTHER freeze-dried whole strawberry powder 12 g
  • OTHER freeze-dried control powder 0 g strawberry

Study Locations (1)

Illinois

  • Clinical Nutrition Research Center - Chicago

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2022-08-31
Est. Completion 2026-01-28
Phase NA

What the Registry Record Tells You About NCT06173765

The ClinicalTrials.gov registry entry for NCT06173765 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (77% lower). The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 3 interventions - of which freeze-dried whole strawberry powder 36 g powder is the first listed.

NCT06173765 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06173765 about?

NCT06173765 is a clinical study titled "Understanding Dose Related Effects of Strawberry". The proposed research is designed to extend previous research findings building on the knowledge of strawberries as fruits that support a healthy immune and vascular system. The proposed research leverages a recently funded proposal by the USDA to study in greater depth inflammation, glucoregulation...

What is the current status of trial NCT06173765?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2022-08-31. Estimated completion is 2026-01-28.

What conditions does trial NCT06173765 study?

This clinical trial studies the following conditions: Inflammation, Insulin Resistance, Pre Diabetes, Insulin Sensitivity.

What interventions are being tested in trial NCT06173765?

The interventions under investigation include: freeze-dried whole strawberry powder 36 g powder (OTHER), freeze-dried whole strawberry powder 12 g (OTHER), freeze-dried control powder 0 g strawberry (OTHER).

Who is sponsoring clinical trial NCT06173765?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06173765 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.